The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cancer, Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology, Oncology |
| Healthy: | No |
| Age Range: | 9 - 18 |
| Updated: | 8/11/2018 |
| Start Date: | November 2011 |
| End Date: | December 2018 |
The proposed study is a pilot study and a first step towards developing an optimized HPV
vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.
vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.
Inclusion Criteria:
- 9-18-year-old girls who have CKD stages 3 or 4 (Glomerular filtration rates 15-59
mL/min/1.73m2).
- 9-18-year-old girls who are on dialysis.
- 9-18-year-old girls who have had a functioning kidney transplant for longer than 6
months and are on the same immunosuppression regimen.
- Healthy 9-18-year-old girls
Exclusion Criteria:
- Pregnancy, fever, allergy to any vaccine component, any immune disorder and any blood
product received in the previous 6 months.
We found this trial at
1
site
Click here to add this to my saved trials
